Product Information
POTASSIUM CL ER 8 MEQ CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $0.0998 per EA under NDC 43547055210. Its NADAC has been published 278 times since Jun 9, 2021.
FDA first approved this application on Jun 11, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547055210
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209026FDA Approved
6/11/2019
TE Code
AB
On Market Since
3/14/2019
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has been published 278 times since Jun 9, 2021, and over the history we have for it it has declined 64.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0998 per EA |
|---|---|
| All-time high | $0.3060 (Sep 15, 2021) |
| All-time low | $0.0914 (Jul 22, 2026) |
| 52-week high | $0.1336 |
| 52-week low | $0.0914 |
| Median price | $0.1457 |
| Average price | $0.1566 |
| Largest weekly change | -44.0% (Nov 23, 2022) |
| Weeks tracked | 278 |
| Tracking since | Jun 9, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the potassium chloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
potassium chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 8 MEQ CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ CAPSULE, manufactured by Solco Healthcare US LLC, is $0.0998 per EA (NDC 43547055210), effective Sep 30, 2026.
How has the price of POTASSIUM CL ER 8 MEQ CAPSULE changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has declined 64.6%. It has been tracked across 278 weekly CMS publications since Jun 9, 2021.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ CAPSULE?
Since Jun 9, 2021, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has ranged from a low of $0.0914 (Jul 22, 2026) to a high of $0.3060 (Sep 15, 2021), with a median of $0.1457 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CL ER 8 MEQ CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POTASSIUM CL ER 8 MEQ CAPSULE?
POTASSIUM CL ER 8 MEQ CAPSULE (NDC 43547055210) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.